Pricing Log in Create free account

OKYO Pharma Limited Sponsored ADR (OKYO) vs Rani Therapeutics Holdings, Inc. (RANI)

OKYO Pharma Limited Sponsored ADR and Rani Therapeutics Holdings, Inc. are both Biotechnology companies. OKYO Pharma Limited Sponsored ADR and Rani Therapeutics Holdings, Inc. are of similar size ($79.9M and $75.1M). OKYO Pharma Limited Sponsored ADR has the higher net margin (0.00% vs −597.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, OKYO Pharma Limited Sponsored ADR leads on 6 and Rani Therapeutics Holdings, Inc. on 5.

Valuation

Metric OKYO RANI Biotechnology median
P/E n/m n/m 10.26
P/S n/m 19.28 9.18
P/B 85.82 2.03 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 11.82 8.98
Earnings yield 0.00% (51.92%) (34.89%)
Free cash flow yield (0.90%) (20.90%) (24.52%)

Profitability

Metric OKYO RANI Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin — (652.78%) 0.00%
Net margin 0.00% (596.97%) 0.00%
Free cash flow margin 0.00% (402.83%) 0.00%
Return on equity 0.00% (155.24%) (50.12%)
Return on assets 0.00% (77.54%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OKYO RANI Biotechnology median
Revenue growth (TTM) — 78.73% 6.26%
EPS growth (last fiscal year) (101.34%) 57.14% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OKYO RANI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.43 5.31 4.89
Net debt to EBITDA 2.42 1.33 1.01

Dividend

Metric OKYO RANI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OKYO RANI Biotechnology median
Market cap 75.05m 79.85m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack